Synthesis and antiarrhythmic activity of new 1-[1-[2-[3-{alkylamino}-2-hydroxypropoxy]phenyl]vinyl]-1H-imidazoles and related compounds
作者:Masaru Ogata、Hiroshi Matsumoto、Kimio Takahashi、Sumio Shimizu、Shiro Kida、Motohiko Ueda、Sadatoshi Kimoto、Masao Haruna
DOI:10.1021/jm00375a010
日期:1984.9
Various 1-[1-[2-[3-(alkylamino)-2-hydroxypropoxy]phenyl]vinyl]-1 H-azoles were synthesized and investigated for beta-adrenoceptor-blocking and antiarrhythmic activities. Although no compounds showed more potent beta-blocking effects than propranolol in the isolated guinea pig right atria, many compounds exhibited significant antiarrhythmic effects against aconitine or ischemic arrhythmia in mice or
合成了各种1- [1- [2- [3-(烷基氨基)-2-羟基丙氧基]苯基]乙烯基] -1 H-唑,并对其β-肾上腺素受体阻断和抗心律不齐的活性进行了研究。尽管在分离的豚鼠右心房中没有化合物比普萘洛尔显示出更强的β受体阻滞作用,但许多化合物在小鼠或狗中对乌头碱或缺血性心律不齐表现出明显的抗心律不齐作用。1- [2,5-二氯-6- [1-(1H-咪唑-1-基)-乙烯基]苯氧基] -3-[(1-甲基乙基)氨基] -2-丙醇盐酸盐(48)(711389-由于其抗心律失常作用优于奎尼丁,二吡喃酰胺或普萘洛尔,因此被选为人类临床评估的候选药物。描述了(R)-(+)-和(S)-(-)-48的不对称合成,并且证明48的抗心律不齐作用没有立体特异性。